How to Obtain AMA PRA Category 1 Credit

  1. Click the link under “Next Step” (near bottom of this page) to open and read the CME activity.
  2. Return to this page to advance to the CME posttest.
  3. Login to your myCME account.
  4. Complete the CME posttest.
  5. Complete the registration / evaluation form.
  6. Print your personalized CME certificate.

Technical Requirements

 

Advances in Lung Cancer Evaluation
and Management

Lung Cancer Screening:
Examining the Issues

First Step: Review Information Below to Begin Activity

This article is available for reading but no longer available to take the post-test and receive CME credit. You can visit the Home Page of the Cleveland Clinic Journal of Medicine for more Journal Articles.

Estimated Time of Completion: 15 minutes

Description

This educational activity from the Cleveland Clinic Journal of Medicine reviews important issues in lung cancer screening, including the impact of screening on mortality, the potential for overdiagnosis, cost-effectiveness, and implications for future screening programs.

Objectives

Upon completing this activity, participants will be able to:

  1. Describe the principles of a successful cancer screening program.
  2. Discuss the current state of lung cancer screening trials.
  3. Identify potential issues with computed-tomography–based lung cancer screening programs.

Target Audience

This activity is directed to medical oncologists, radiation oncologists, pulmonologists, thoracic surgeons, internists, and nurses.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Directors and Supplement Editors

Nathan Pennell, MD, PhD
Assistant Professor, Department of Solid Tumor Oncology,
Taussig Cancer Institute, Cleveland Clinic,
Cleveland, OH

Peter Mazzone, MD
Director of Education, Lung Cancer Program,
and Pulmonary Rehabilitation Program;
Respiratory Institute, Cleveland Clinic,
Cleveland, OH

Faculty

Peter Mazzone, MD
Director of Education, Lung Cancer Program,
and Pulmonary Rehabilitation Program;
Respiratory Institute, Cleveland Clinic,
Cleveland, OH

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:

Peter Mazzone, MD (Activity Director)
  Member of advisory committees:

Boehringer Ingelheim and Oncimmune

  Research support: Metabolomx

The following faculty has indicated he has no relationship which, in the context of his contribution, could be perceived as a potential conflict of interest:

Nathan A. Pennell, MD, PhD

All other planners, CME staff, and content reviewers reported that they have no relevant financial relationships to disclose.

Acknowledgment

The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for support of this activity from Pfizer Inc., Genentech, Inc., and Merck & Co., Inc.

Next Step:

(Article opens in new tab / window; return to this window to complete the activity).

This CME activity was produced by the Cleveland Clinic Journal of Medicine
and the Cleveland Clinic Center for Continuing Education.

CME Disclaimer